Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Anorectics and pulmonary hypertension].

J Bíbová¹, V Hampl

¹Ustav fyziologie 2. LF UK, Praha, Motol.

Casopis Lekaru Ceskych

|June 6, 2000

Summary

Appetite-suppressant drugs (anorectics) can cause life-threatening pulmonary hypertension by affecting serotonin levels and inhibiting potassium channels, leading to increased calcium and vasoconstriction. Pre-existing defects may increase susceptibility to this serious side effect.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hypoxia-inducible factors activator, roxadustat, increases pulmonary vascular resistance in rats.

Physiological research·2024

Same author

Simvastatin and dehydroepiandrosterone sulfate effects against hypoxic pulmonary hypertension are not additive.

Physiological research·2022

Same author

Alcohol and fetoplacental vasoconstrictor reactivity.

Physiological research·2018

Same author

Nitric oxide elevation in polytrauma is driven by oxygen radicals.

Physiological research·2018

Same author

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162].

Redox biology·2017

Same author

The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.

Oncogene·2017

Area of Science:

Cardiovascular Pharmacology
Pulmonary Medicine
Pharmacology

Context:

Anorectics, or appetite-suppressant drugs, are frequently prescribed but linked to severe adverse events.
A historical association exists between anorectic use and primary pulmonary hypertension, noted since the 1960s.
Recent studies confirm newer anorectics like fenfluramine significantly elevate pulmonary hypertension risk.

Purpose:

To investigate the mechanisms by which anorectics contribute to the development of pulmonary hypertension.
To explore the role of serotonin and ion channel activity in anorectic-induced pulmonary vasoconstriction.

Summary:

Anorectic drugs may increase pulmonary hypertension risk through elevated plasma serotonin and direct effects on pulmonary vascular smooth muscle cells.
These drugs inhibit potassium channel activity, causing cell membrane depolarization and subsequent calcium influx, leading to vasoconstriction.
The severity of vasoconstriction may be exacerbated by pre-existing defects in counter-regulatory mechanisms, such as nitric oxide production.

Impact:

Understanding these mechanisms is crucial for assessing the cardiovascular risks associated with anorectic medications.
This research highlights the need for careful patient selection and monitoring when prescribing appetite suppressants.
Findings may inform the development of safer alternatives or preventative strategies for anorectic-induced pulmonary hypertension.

Related Experiment Videos